Kinnate Biopharma Inc
(KNTE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 168,002 | 182,389 | 365,462 | N/A | N/A |
| Marketable Securities | 87,017 | 65,808 | 31,398 | N/A | N/A |
| TOTAL | $258,780 | $251,172 | $400,203 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 286 | 283 | 368 | N/A | N/A |
| Investments And Advances | 145,136 | 134,910 | 0 | 0 | 0 |
| Other Non-Current Assets | 461 | 0 | 0 | 0 | 0 |
| TOTAL | $145,883 | $135,193 | $368 | $N/A | $N/A |
| Total Assets | $404,663 | $386,365 | $400,571 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,334 | 3,212 | 3,940 | 0 | 0 |
| Accrued Expenses | 6,989 | 4,581 | 3,364 | N/A | N/A |
| TOTAL | $8,323 | $7,793 | $7,304 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 35,000 | 0 | 0 | 0 | 0 |
| TOTAL | $35,000 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $43,323 | $7,793 | $7,304 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,676 | 43,504 | N/A | N/A | N/A |
| Common Shares | 4 | 4 | 4 | N/A | N/A |
| Retained earnings | -92,231 | -70,786 | -53,329 | N/A | N/A |
| Other shareholders' equity | -74 | -40 | -9 | 0 | 0 |
| TOTAL | $361,340 | $378,572 | $393,267 | $N/A | $N/A |
| Total Liabilities And Equity | $404,663 | $386,365 | $400,571 | $0 | $0 |